| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/07/2007 | CN1303202C Ethanol feedback control flow added high density fermentation method for yeast and use thereof |
| 03/06/2007 | US7186898 Nucleic acid molecules from maize and their use for the production of modified starch |
| 03/06/2007 | US7186820 Antibody for use in the treatment of rheumatic and osteoarthritis |
| 03/06/2007 | US7186818 DNA encoding soluble variants of human OX2 receptors |
| 03/06/2007 | US7186817 Comprises hydrolase for degradation of phytate and increased digestibility and nutrient quality of plants and animal feeds |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186808 Isolated monoclonal antibody encoded by clone accession number PTA-4889. |
| 03/06/2007 | US7186805 Fusion proteins; for inhibition of cognate receptor |
| 03/06/2007 | US7186803 Human vanilloid receptor VR3 protein |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186800 Fc domains of immunoglobulins; fas genes/proteins; drug screening |
| 03/06/2007 | US7186795 Lactoferricin gene and transformant expressing lactoferricin |
| 03/06/2007 | US7186546 Process for the preparation of alkaline protease |
| 03/06/2007 | US7186540 Thermostable glutaminase and thermostable glutaminase gene |
| 03/06/2007 | US7186537 Human GAK-related gene variants associated with lung cancer |
| 03/06/2007 | US7186534 Screening for predisposition to cancer, screening for enzyme inhibitors |
| 03/06/2007 | US7186531 L-threonine producing bacterium belonging to the genus Escherichia and method for producing L-threonine |
| 03/06/2007 | US7186529 Genetic engineered human cell contains an endogenous EPO (erythropoietin) gene in linkage with a heterologous viral promoters, SV40 or Cytomegalo virus |
| 03/06/2007 | US7186528 Method for preparing a physiologically active IL-18 polypeptide |
| 03/06/2007 | US7186527 Goodpasture antigen binding protein |
| 03/06/2007 | US7186525 Providing a cell-free system comprising a bacterial cell-free extract; adding a DNA template comprising a bacterial promoter with at least one UP element to said cell free system; recovering the synthesized RNA |
| 03/06/2007 | US7186524 Preparing transgenic vectors capable of transformation, propagation and expression of cell surface ligand binding activity in host cells; drug screening |
| 03/06/2007 | US7186511 Oxidase |
| 03/06/2007 | US7186503 Compounds and methods for modulating activation of NF-κB |
| 03/06/2007 | US7186412 Fusion proteins of Mycobacterium tuberculosis |
| 03/06/2007 | CA2141670C Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 03/01/2007 | WO2007025181A2 Aureobasidin a synthetase |
| 03/01/2007 | WO2007024743A2 Proteolysis resistant antibody preparations |
| 03/01/2007 | WO2007024718A2 Genetically modified host cells and use of same for producing isoprenoid compounds |
| 03/01/2007 | WO2007024368A2 Compositions and methods to control angiogenesis with cupredoxins |
| 03/01/2007 | WO2007024222A1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 03/01/2007 | WO2007023782A1 Neutralizing antibody directed against killer toxin-like protein, and use thereof |
| 03/01/2007 | WO2007022668A1 Important lymphocyte activation regulatory protein pkd2 and uses thereof |
| 03/01/2007 | WO2006127682A3 Novel methods |
| 03/01/2007 | WO2006113220A9 Transgenic mammals expressing human preproinsulin |
| 03/01/2007 | WO2006085954A3 In vitro reconstitution of ribonucleoprotein complexes, and methods of use therefor |
| 03/01/2007 | WO2006083240A3 Microbially expressed xylanases and their use as feed additives and other uses |
| 03/01/2007 | WO2005124341A3 Stable isotope labeled polypeptide standards for protein quantitation |
| 03/01/2007 | WO2004081032A3 Novel litaf binding site peptides and methods of using the same |
| 03/01/2007 | US20070049743 Novel nucleic acids and polypeptides |
| 03/01/2007 | US20070049736 Cytokine receptor specific immunoglobulin for prevention and treatment of infection, cell proliferative and autoimmune disorders |
| 03/01/2007 | US20070049730 for treatment of disorders which are mediated at least in part by Hedgehog (Hh) especially Desert hedgehog (Dhh) in particular testicular cancer |
| 03/01/2007 | US20070049533 Analogs of peptides corresponding to class I major histocompatibility complex (MHC)-restricted T-cell epitopes that contain amino acid substitutions of norleucine and/or norvaline; intranodal administration a an immunopotentiating agent |
| 03/01/2007 | US20070049532 Selecting by phage display a peptide that binds to nerve growth factor (NGF), and preparing a fusion protein with an Fc domain; biological half-life increases |
| 03/01/2007 | US20070049530 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070049529 Reducing the growth of cancer cells in a mammal by administering polypeptide of the invention; |
| 03/01/2007 | US20070049527 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |
| 03/01/2007 | US20070049525 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048862 Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines |
| 03/01/2007 | US20070048861 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses |
| 03/01/2007 | US20070048847 Methods of producing antibodies to cytokine receptor |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048845 Cytokine zalpha11 ligand fusion proteins |
| 03/01/2007 | US20070048844 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 03/01/2007 | US20070048843 Homogeneous preparations of IL-28 and IL-29 |
| 03/01/2007 | US20070048842 using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation |
| 03/01/2007 | US20070048841 Viricidal polypeptide for prevention and treatment of hepatitis infection |
| 03/01/2007 | US20070048840 Human Zven polynucleotides |
| 03/01/2007 | US20070048839 Novel amylolytic enzyme extracted from bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 03/01/2007 | US20070048838 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 03/01/2007 | US20070048837 Site specific protein modification |
| 03/01/2007 | US20070048836 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 03/01/2007 | US20070048835 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048834 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048833 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048832 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048831 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048830 Polynucleotide that encodes a protein composed of a first polypeptide disulfide-bonded to a second polypeptide that stimulates proliferation, differentiation, or migration of mesenchymal cells; monoclonal and single-chain antibodies; activating a cell-surface platelet-derived growth factor receptor |
| 03/01/2007 | US20070048829 polynucleotide that encode polypeptides having mitogenic activity on human aortic smooth muscle cells |
| 03/01/2007 | US20070048828 Comprises fusion protein comprising platelet derived growth factor for treating connective tissue, tumor and bone disorders; used to stimulate the production of bone and/or connective tissue in both humans and non-human animals |
| 03/01/2007 | US20070048827 Mammalian transforming growth factor beta-9 |
| 03/01/2007 | US20070048826 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048825 Compositions and methods for the diagnosis and treatment of tumor |
| 03/01/2007 | US20070048824 Interleukin-17 receptor homologue |
| 03/01/2007 | US20070048823 Compositions and Methods for Producing Apolipoprotein Gene Products in Lactic Acid Bacteria |
| 03/01/2007 | US20070048822 activating tyrosine phosphorylation of ErbB4 in an ErbB4-expressing cell by administering to the cell a polypeptide comprising the amino acid sequence of neuregulin 3 |
| 03/01/2007 | US20070048821 Canine influenza vaccines |
| 03/01/2007 | US20070048820 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 03/01/2007 | US20070048819 Canine influenza vaccines |
| 03/01/2007 | US20070048818 Human secreted proteins |
| 03/01/2007 | US20070048817 Synthesiing a cyclic dipeptide (Albonoursin) by transforming a host cell with a vector having a specific sequence and incubating to allow expression of a cyclodipeptide synthase that subsequently catalizes the cyclization of two amino acids |
| 03/01/2007 | US20070048810 ATP-binding cassette protein responsible for cytotoxin resistance |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048798 Expression vector; a prokaryotic origin of replication, a transcriptional initiation DNA element, a polynucleotide sequence, and a transcriptional terminator; optimizing codons and mRNA secondary structure for translation in E. coli; ultrafiltration |
| 03/01/2007 | US20070048784 Novel human hydrolase family members and uses thereof |
| 03/01/2007 | US20070048781 Mammalian cytokines; related reagents and methods |
| 03/01/2007 | US20070048780 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors; kits for diagnosing infection and vaccines |
| 03/01/2007 | US20070048774 Continuous in-vitro evolution |
| 03/01/2007 | US20070048772 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 03/01/2007 | US20070048771 Nucleic acid of given sequence; useful as modulating agents in regulating cellular processes |
| 03/01/2007 | US20070048754 Epidermal growth factor receptor mutations |
| 03/01/2007 | US20070048753 Sodium channel protein type III alpha-subunit splice variant |
| 03/01/2007 | US20070048748 Mutant polymerases for sequencing and genotyping |
| 03/01/2007 | US20070048329 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 03/01/2007 | US20070048326 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | US20070048311 ANTI-INTERFERON-alpha ANTIBODIES |
| 03/01/2007 | US20070048309 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048308 Nucleic acid encoding cytokine receptor zcytor17 |
| 03/01/2007 | US20070048307 Nucleotide sequences coding cytokine receptor for identifying modulators for treating blood disorders associated with cancer treatment |